Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - 53rd Annual Meeting & Exposition of the American Society of Hematology
Targeted Therapy for Complement Inhibition: Preventing Life-threatening Thrombosis
San Diego, California / December 10-13, 2011
San Diego - Paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) are 2 diseases driven by the complement system that respond to a monoclonal antibody (MAb) that binds to the human C5 complement protein and...
MEDICAL FRONTIERS - 53rd Annual Meeting & Exposition of the American Society of Hematology
Targeted Therapies Providing Major Clinical Advances in Myeloproliferative Neoplasms
San Diego, California / December 10-13, 2011
San Diego - Progress in understanding the molecular pathophysiology of myeloproliferative neoplasms (MPNs) is generating new therapies that appear capable of inhibiting key steps in the disease process. In myelofibrosis, polycythemia vera...
PHYSICIAN PERSPECTIVE - Viewpoint based on presentations at the 53rd Annual Meeting & Exposition of the American Society of Hematology
Maintenance Therapy as an Emerging Standard for Improving Survival in Multiple Myeloma
San Diego, California / December 10-13, 2011
Reviewed and edited by: Donna E. Reece, BA, MD, FRCPCDirector, Program for Multiple Myeloma and Related Diseases Princess Margaret Hospital Associate Professor of Medicine University of Toronto Toronto, Ontario Introduction One of...
RESOURCE LINE - Nutrition
Malnutrition: A Serious Condition Requiring Early Evidence-based Nutritional Intervention
December 2011
Among key components of disease management, evidence-based data indicate that proper nutritional intervention canimprove outcomes and in many cases lower costs of care. Routine early nutritional screening permits intervention toprevent or...
MEDICAL FRONTIERS - 2011 Advances in Inflammatory Bowel Diseases Crohn’s and Colitis Foundation (CCF) Clinical & Research Conference
Remission with Complete Mucosal Healing Is the Emerging Treatment Goal for Ulcerative Colitis and Crohn’s Disease
Hollywood, Florida / December 1-3, 2011
Hollywood - In patients with an inflammatory bowel disease (IBD), whether ulcerative colitis or Crohn’s disease, outcome is superior when remission includes mucosal healing. The data are so persuasive that there is now an exploration...
PRIORITY PRESS - Inflammatory Bowel Disease 10th International Meeting
Lessons on Optimizing 5-ASA Therapy and Bowel Preparation
Vienna, Austria / November 17-19, 2011
Chief Medical Editor: Dr. Léna Coïc, Montréal, Quebec When treating patients with inflammatory bowel disease (IBD), Prof. Michael Kamm, St. Vincent’s Hospital, Melbourne, Australia, told delegates, “When...
MEDI-NEWS Based on Vesikari et al. N Engl J Med 2011;365:1406-16.
Novel Adjuvant in Trivalent Inactivated Influenza Vaccine for Very Young Children
A highly effective oil-in-water emulsion adjuvant was recently incorporated into the trivalent influenza vaccine (ATIV) and tested in a large cohort of children between 6 and <72 months of age. Results indicate that the new ATIV is...
PRIORITY PRESS - Critical Care Canada Forum 2011
Hyponatremia in the Hospital Setting
Toronto, Ontario / November 13-16, 2011
Toronto - Hyponatremia is one of the most common electrolyte disturbance occurring in clinical practice in the hospital setting. It is associated with substantial morbidity and mortality in patients yet its diagnosis can be quite delayed...
PRIORITY PRESS - American Heart Association (AHA) Scientific Sessions 2011
Differences Between Anticoagulants in Percutaneous Coronary Procedures
Orlando, Florida / November 12-16, 2011
Orlando - Anticoagulants and antiplatelets are considered essential for preventing recurrent thrombotic events in patients with an acute coronary syndrome or advanced cardiovascular (CV) disease. Once the standard, unfractionated heparin...